SALT LAKE CITY — Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read sequencing, today announced the addition of three Oxford Nanopore–developed research-use-only (RUO) assays to its service portfolio: a Pharmacogenomics (PgX) panel, Telomere Sequencing, and mRNA Vaccine Quality Control. Headquartered in a 20,000sqft CLIA-registered laboratory, […]
Caption: TheraPEAK 293-GT media system for suspension HEK203 cell lines. Caption: TheraPEAK AmpliCell Recombinant Interleukin Cytokines. AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK® 293-GT® Medium System aims to help accelerate development timelines and improve consistency from research through to GMP gene therapy production Basel, Switzerland […]
Launch of End-to-End Workflow for AVITI and AVITI24™ Enabling Sample to Sequencer in as Little as Five Hours — Twist Gains Exclusive Access to the new, co-developed Trinity Freestyle™ Sequencing Workflow – SOUTH SAN FRANCISCO, Calif. & SAN DIEGO–Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a […]
MaxCyte’s Flow Electroporation® Technology will support efficient gene delivery to advance Moonlight Bio’s engineered T cell therapies ROCKVILLE, Md. — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced the signing of a Strategic Platform License (SPL) agreement with […]
• AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing • TheraPEAK® 293-GT® Medium System aims to help accelerate development timelines and improve consistency from research through to GMP gene therapy production Basel, Switzerland – Life Science Newswire – Lonza, one of the world’s largest contract development and manufacturing […]
Brings more than three decades of leadership experience in the life sciences industry RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Gregory T. Lucier to its Board of Directors. Mr. Lucier brings […]
LIVERMORE, Calif. — Precision Cell Systems (PCS) today announced the acquisition of BennuBio, marking a significant entry into the rapidly growing 3D cell culture market. According to Grand View Research, the global market was valued at over $1.7 billion and is projected to exceed $3.2 billion by 2030. The acquisition brings BennuBio’s Velocyt™ imaging flow […]
EMERYVILLE, Calif. — Slingshot Biosciences (“Slingshot”) today announced two additions to its TruCytes™ cell mimic product line designed to accelerate cell therapy and stem cell research, development, and manufacturing programs by assuring the reproducibility of results. The use of TruCytes™ Potency CD20 controls provides consistent mechanism-of-action (MoA) potency readouts, while TruCytes™ CD34 Stem Cell Gating […]
WILMINGTON, N.C. — The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden. Thermo Fisher Bioanalytical lab The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to drive innovation and […]
New business focuses on developing data assets, software, and AI to fuel life science breakthroughs Expands pharma access to large omics datasets to advance target discovery and drug development SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic insights driven by the need […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
